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According to our earlier data most steroid end hormones and some intermediate metabolites of the steroidogenesis are able 
to inhibit the production of free radical superoxide anion. 
In our study we intended to investigate, whether gene-expression of the important antioxidant enzyme superoxide dismutase 
(SOD) changes after incubation with steroidal compounds . 
Peripheral blood samples were collected from healthy volunteers (men and women, aged 20-30 years). Af te r the neutrophil 
cell separation four different steroid treatments (oestradiol, progesterone, testosterone and Cortisol; all in 10 s M concentration, 
for 2 hours and at 37°C ) were performed on 5 million cells. Total R N A was isolated f rom the treated and control cells, then 
reverse transcription and real t ime polymerase chain reaction (RT PCR) were performed on each sample. SYBR Green assays 
were used for the relative quantification. The SOD, gene expression was compared to G A P D H housekeeping gene expression 
level (incubation with steroidal compounds mentioned above did not alter the expression of this gene in our pilot study). 
Upregulated SOD, gene expression levels were found after treatment with each steroidal cmpounds . In case of estradiol 
14.1 fold, progesterone and Cortisol 11.3fold increase in average was detected. The largest change (almost twenty - 1 9 . 7 f o l d 
rise) was caused by testosterone. The standard deviations of the ddCT values were within one in each treatment. 
Based on these data the antioxidant effect of steroid endhormones might be caused at least in part by the enhancement 
of the S O D gene expression. These results may have innovative pharmacological importance in connect ion wih free radical 
mediated disorders. 
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The receptors, kinases, and nuclear transcription factors affected by metals and metal- induced oxidative stress are associated 
with cancer growth and spreading. The formaldehyde is in connection with redox homeostasis . H C H O can be fo rmed in 
transmethylating reactions. Data show the important role of H C H O in proliferative, as well as in apoptotic processes. 
Therefore we were interested in studying erythrocyte metal element status, redox homeostasis and transmethylating ability 
of randomly chosen, operated, middle aged 68 colon and/or prostate tumourous patients and 4 6 healthy volunteers in both 
genders. 
Tumour markers (CEA. C A 19-9. AFP. PSA) and routine laboratory parameters in sera, redox parameters (scaverger- and 
reducing ability, SOD. GSHPx) in plasma and erythrocytes, bounded HCHO. H b A l c . protoporphyrin and metal e lement 
concentrations in erythrocytes were measured. 
We found significant differences in the metal and redox homeostasis between control and operated patients. Significant 
changes in erythrocyte function can be observed in transmethylating ability and protoporphyrin concentrat ions as well . The 
bounded H C H O concentrations were significantly lower in tumourous patients than in healthy controls. 
These changes of erythrocytes were similar in operated colon and prostate tumourous patients. We hypothesize that there 
are similar changes in all other tumour types. 
Supporting: ETT 12/2006: ETT354/2006. 
42 
